SCHEMBL4777430

SCHEMBL4777430

Cc1cc(-c2ccccc2Cl)cc(C(=O)O)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MEN1 O00255 1/20 0.50
KMO O15229 1/20 0.43
CYP2A6 P11509 1/20 0.43
ALPL P05186 1/20 0.42
GPR35 Q9HC97 1/20 0.42
DHODH Q02127 2/20 0.41
KDM5A P29375 1/20 0.41
SCN9A Q15858 1/20 0.41
GRM2 Q14416 1/20 0.41
USP2 O75604 1/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
LTB4R Q15722 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19537421 0.82 CYP2A6 (0.52) KMT2ACYP2A6KDM4EALDH1A1HPGD
SCHEMBL4774392 0.81 DHODH (0.49) KMT2AMEN1KMODHODHKDM4E
SCHEMBL4771510 0.79 ALOX15 (0.51) GPR35DHODHKDM5AKDM4EALDH1A1
SCHEMBL4778544 0.78 DHODH (0.50) KMT2AMEN1KMODHODHKDM4E
SCHEMBL1793529 0.77 NPC1 (0.56) KMT2AKDM4EALDH1A1HPGDTP53
SCHEMBL4772052 0.76 ALOX15 (0.46) KMOGPR35KDM4EALDH1A1SMN1; SMN2
SCHEMBL17595182 0.76 MCL1 (0.53) DHODHKDM5AKDM4EALDH1A1HPGD
SCHEMBL4779426 0.76 KMO (0.47) KMT2AKMOGPR35ALDH1A1SMN1; SMN2
SCHEMBL27909628 0.74 ALDH1A1 (0.50) KMT2AMEN1CYP2A6DHODHUSP2
SCHEMBL4774543 0.74 KMO (0.53) KMOGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101384554-B Pyridine-2-carboxamide derivatives HOFFMANN LA ROCHE 2012-08-08 CN claimed
CN-101384554-A Pyridine-2-carboxamide derivatives HOFFMANN LA ROCHE (CH) 2009-03-11 CN claimed
EP-1987003-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-11-05 EP claimed
WO-2007093542-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-08-23 WO claimed
US-20070197553-A1 4-Aryl-pyridine-2-carboxyamide derivatives HOFFMANN-LA ROCHE INC. 2007-08-23 US claimed
CN-101384554-B Pyridine-2-carboxamide derivatives HOFFMANN LA ROCHE 2012-08-08 CN disclosed
CN-101384554-A Pyridine-2-carboxamide derivatives HOFFMANN LA ROCHE (CH) 2009-03-11 CN disclosed
EP-1987003-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-11-05 EP disclosed
WO-2007093542-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-08-23 WO disclosed
US-20070197553-A1 4-Aryl-pyridine-2-carboxyamide derivatives HOFFMANN-LA ROCHE INC. 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197553-A1 4-Aryl-pyridine-2-carboxyamide derivatives GRM2, GRM1, GRM3 KMT2A 429/4885MEN1 3576/4885KMO 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.